This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

British Journal of Clinical Pharmacology


Acute interaction between oral glucose (75 g as Lucozade) and inorganic nitrate: Decreased insulin clearance, but lack of blood pressure‐lowering

Pages: 1443-1453

Article date: July 2019

Authors: Christopher N. Floyd, Satnam Lidder, Joanne Hunt, Sami A. Omar, Karen McNeill, Andrew J. Webb

Effects of proton pump inhibitors, esomeprazole and vonoprazan, on the disposition of proguanil, a CYP2C19 substrate, in healthy volunteers

Pages: 1454-1463

Article date: July 2019

Authors: Ryohkan Funakoshi, Yukana Tomoda, Toshiyuki Kudo, Kenichi Furihata, Hiroyuki Kusuhara, Kiyomi Ito

Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first‐line immunochemotherapy

Pages: 1495-1506

Article date: July 2019

Authors: Candice Jamois, Ekaterina Gibiansky, Leonid Gibiansky, Vincent Buchheit, Denis Sahin, Guillaume Cartron, Robert Marcus, Wolfgang Hiddemann, John F. Seymour, Jonathan C. Strefford, Chantal E. Hargreaves, Georgina Meneses‐Lorente, Nicolas Frey, Günter Fingerle‐Rowson

Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016

Pages: 1598-1606

Article date: July 2019

Authors: Mikkel Højlund, Anton Pottegård, Erik Johnsen, Rune A. Kroken, Johan Reutfors, Povl Munk‐Jørgensen, Christoph U. Correll

Effect of CYP3A inhibitors on the pharmacokinetics of pevonedistat in patients with advanced solid tumours

Pages: 1464-1473

Article date: July 2019

Authors: Hélène Faessel, John Nemunaitis, Todd M. Bauer, A. Craig Lockhart, Douglas V. Faller, Farhad Sedarati, Xiaofei Zhou, Karthik Venkatakrishnan, R. Donald Harvey

Key enablers and barriers to implementing adaptive pathways in the European setting

Pages: 1427-1433

Article date: July 2019

Authors: Juan Carlos Rejon‐Parrilla, Pall Jonsson, Jacoline C. Bouvy

Relationship between allograft cyclosporin concentrations and P‐glycoprotein expression in the 1st month following renal transplantation

Pages: 1015-1020

Article date: May 2019

Authors: Benedetta C. Sallustio, Benjamin D. Noll, Janet K. Coller, Jonathan Tuke, Graeme Russ, Andrew A. Somogyi

Pharmacokinetics of ticarcillin–clavulanate in premature infants

Pages: 1021-1027

Article date: May 2019

Authors: Kevin M. Watt, Christoph P. Hornik, Stephen J. Balevic, Gratias Mundakel, C. Michael Cotten, Barrie Harper, Daniel K. Benjamin, Ravinder Anand, Matthew Laughon, P. Brian Smith, Michael Cohen‐Wolkowiez, on behalf of the Best Pharmaceuticals for Children Act — Pediatric Trials Network Steering Committee, on behalf of the Best Pharmaceuticals for Children Act — Pediatric Trials Network Steering Committee

Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults

Pages: 960-969

Article date: May 2019

Authors: Stephani L. Stancil, Robin E. Pearce, Rachel F. Tyndale, Gregory L. Kearns, Carrie A. Vyhlidal, J. Steven Leeder, Susan Abdel‐Rahman

Central nervous system effects of the histamine‐3 receptor antagonist CEP‐26401, in comparison with modafinil and donepezil, after a single dose in a cross‐over study in healthy volunteers

Pages: 970-985

Article date: May 2019

Authors: Anne C. Baakman, Rob Zuiker, Joop M.A. Gerven, Nicholas Gross, Ronghua Yang, Michael Fetell, Ari Gershon, Yossi Gilgun‐Sherki, Edward Hellriegel, Ofer Spiegelstein